Filter
833
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
84
New Publications
196
Language
Document type
No document type
369
Studies & Reports
183
Guidelines
149
Manuals
59
Strategic & Response Plan
41
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Global
40
India
28
Kenya
27
Nigeria
22
Western and Central Europe
22
Ethiopia
20
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Eastern Europe
10
Philippines
9
Tanzania
9
Rwanda
9
Ghana
8
Zimbabwe
8
Malawi
8
Namibia
8
Latin America and the Carribbean
8
Nepal
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Africa
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
260
Clinical Guidelines
90
Public Health
45
Pharmacy & Technologies
35
Key Resources
31
Women & Child Health
28
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
104
COVID-19
61
TB
46
HIV
43
Rapid Response
42
Mental Health
33
Global Health Education
18
Planetary Health
18
NTDs
18
NCDs
18
Conflict
15
Caregiver
12
Health Financing Toolbox
10
Specific Hazards
7
Disability
6
Ebola
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
Building on Nigeria’s Call to Action to Save Newborn Lives, the Federal Ministry of Health (FMoH) has developed the National Strategy and Implementation Plan for Scale-up of Chlorhexidine. The Ministry incorporated existing maternal, newborn, and child health plans with additional comprehensive st
...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul ...
Migrants and mobile popul ...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
This report aims to raise awareness about the role that the reform of public health laws can play in advancing the right to health and in creating the conditions for people to live healthy lives. By encouraging a better understanding of how public health law can be used to improve the health of the
...
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin
...
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi
...
Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne
...
This document highlights the key aspects of safe health-care waste management in order to guide policy-makers, practitioners and facility managers to improve such services in health-care facilities. It is based on the comprehensive WHO handbook Safe management of wastes from health-care activities (
...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (
...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and
...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i
...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med
...
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
Version 1.1
Department of Mental Health and Substance Abuse
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility
...
WHO Western Pacific Regional Strategy to Reduce Alcohol-Related Harm
